Functional gastrointestinal disorders and mast cells: implications for therapy.
about
New and emerging therapies for the treatment of irritable bowel syndrome: an update for gastroenterologistsMast Cells and Irritable Bowel Syndrome: From the Bench to the BedsideDiagnosis of Irritable Bowel Syndrome: Role of Potential BiomarkersMast cells and gastrointestinal dysmotility in the cystic fibrosis mouseEffects of fluoxetine on mast cell morphology and protease-1 expression in gastric antrum in a rat model of depressionMontelukast in the treatment of duodenal eosinophilia in children with dyspepsia: effect on eosinophil density and activation in relation to pharmacokinetics.Histamine regulation of hyperplastic and neoplastic cell growth in cholangiocytes.Mast cells: versatile gatekeepers of pain.From cytokines to toll-like receptors and beyond - current knowledge and future research needs in irritable bowel syndrome.Irritable bowel syndrome: a microbiome-gut-brain axis disorder?Sex difference in irritable bowel syndrome: do gonadal hormones play a role?Decreased expression of serotonin in the jejunum and increased numbers of mast cells in the terminal ileum in patients with irritable bowel syndrome.The immune system in irritable bowel syndromeDiarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum.Corticotropin releasing factor signaling in colon and ileum: regulation by stress and pathophysiological implicationsThe joint power of sex and stress to modulate brain-gut-microbiota axis and intestinal barrier homeostasis: implications for irritable bowel syndrome.Alterations of Mast Cells in the Esophageal Mucosa of the Patients With Non-Erosive Reflux DiseaseAnalysis of colonic mucosa mast cell count in patients with chronic diarrheaRole of prostaglandin D2 in mast cell activation-induced sensitization of esophageal vagal afferents.Functional somatic syndrome: how it could be relevant to rheumatologists.Intestinal permeability and irritable bowel syndrome.Increased capsaicin receptor TRPV1-expressing sensory fibres in irritable bowel syndrome and their correlation with abdominal painBehavioral and complementary approaches for the treatment of irritable bowel syndrome.Somatostatin modulates mast cell-induced responses in murine spinal neurons and satellite cells.Comparison of Electroacupuncture and Moxibustion for Relieving Visceral Hypersensitivity in Rats with Constipation-Predominant Irritable Bowel Syndrome.Sex hormones in the modulation of irritable bowel syndrome.Mechanisms underlying visceral hypersensitivity in irritable bowel syndrome.Review article: Microscopic colitis--lymphocytic, collagenous and 'mast cell' colitis.Allergic mastocytic gastroenteritis and colitis: an unexplained etiology in chronic abdominal pain and gastrointestinal dysmotility.Neuroanatomy of lower gastrointestinal pain disordersHistamine H₄ receptors in the gastrointestinal tract.Administration of Wasabia koreana Ameliorates Irritable Bowel Syndrome-Like Symptoms in a Zymosan-Induced Mouse Model.Eosinophils, mast cells, nerves and ganglion cells in appendicitis.Abdominal bloating and irritable bowel syndrome like symptoms following microinstillation inhalation exposure to chemical warfare nerve agent VX in guinea pigs.Interplay between inflammation, immune system and neuronal pathways: effect on gastrointestinal motility.Mucosal mast cells are pivotal elements in inflammatory bowel disease that connect the dots: stress, intestinal hyperpermeability and inflammation.Increase of colonic mast cells in obstructed defecation and their relationship with enteric glia.In vivo neutralization of IL-6 receptors ameliorates gastrointestinal dysfunction in dystrophin-deficient mdx mice.Effects of neurotrophin 3 on gastric and colonic motility in awake rats.Neuroimmune interaction and anorectal motility in children with food allergy-related chronic constipation.
P2860
Q26748617-3A96E3CA-4C2C-4183-A640-F2DAF99D5B1BQ26769635-80F00F38-0731-4921-9243-AD1A15F82C8EQ26823844-239F8C39-7896-4390-A063-3297F4874676Q28474618-0CD4EA3B-46BC-40B3-8120-F3F7967AF0E6Q33389951-17F3E33A-0CD6-49C0-9FB7-A879BE1FA7C6Q33443525-5EDFF78A-A1C9-46B3-AA5A-9A56D2054365Q33909909-DB2DD1F5-97D9-4130-844A-22E3B1511B8AQ34225889-6C8EBC8F-D768-4EEA-A24C-C7F33B0833A4Q34298260-B8AC18EA-7C37-46EB-90D6-7BA1C96224CBQ34366837-54A98309-A686-4DBB-9EFF-560B34D2A72AQ34575108-7A9526BA-70E1-40D3-9103-31A439C62AE9Q34606239-7204EF28-8DB7-4530-810A-BD9834A21399Q35587508-9F562BBB-B35A-4FEA-A862-EDDB4EC91D3AQ35761348-D7A5D61F-2751-4F09-A09C-7BA1BC0D191DQ35809342-F8E81DAF-8F32-432C-A6C5-CAC694C2E1A8Q35838055-479FBE64-CD52-42B9-B421-EF71A1729521Q36220260-FCFA57CA-8152-4758-9BB2-7E6AA9B657B2Q36404877-092AE263-90C4-428A-98D4-984388D3E0AAQ36837902-B4823AA0-B172-4AF8-8C65-0766CEBF5BFDQ36847927-84855885-D0CF-4BC9-917B-CBD775BC0F56Q36860979-3A1304D0-56EF-4010-8A87-B996078FEA6AQ36930795-7AA6C5B0-A59F-4E23-9A30-0EBB30926A9AQ37205407-9A2CCA48-1A46-478C-90F2-978C22C6FEE0Q37297955-A1B12799-8A00-4992-B31D-453DADFDD5C0Q37322657-97F8E4C2-8CCD-420F-9E56-2BC8D697DF36Q37629667-775B8AD0-7022-45F6-8643-13ED44BE9CE6Q37871421-B4FCFF5B-9884-4451-9EA3-C1F5191520ECQ37872335-6C8CEEE7-FB28-4423-B9B3-6CD78C568A3AQ38009308-F5C2FFA6-1E2E-42D6-98AE-7E1B9CEC7440Q38191576-C547F910-3AE5-4938-9B55-975F13E1EC95Q38264340-A9E426CC-9485-48FA-8D01-26748EFAF8CDQ38815136-46AD5E92-9B6F-4D1B-B6F8-7CB4903BD835Q42015510-254AB338-D09C-4FDE-A258-EC24DB7519DCQ42170032-F6080B6E-ED4D-49E0-92FD-675FEFAC020DQ42342939-9299057A-B32F-4D1A-9782-0B342B96571BQ42911330-C19CF529-E563-433C-87E3-81153E0B5CDCQ43332454-EDBE4186-D07C-47C5-A9F9-24CC1F50BEBAQ43345556-6B0CC4B8-FD0E-4CAF-974D-5905353157A1Q43354140-BE9C6197-2889-47AA-B4F4-F0B32204CCDAQ43367488-5293753F-A067-4EE4-A05F-BEC05A1E3D1C
P2860
Functional gastrointestinal disorders and mast cells: implications for therapy.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Functional gastrointestinal disorders and mast cells: implications for therapy.
@ast
Functional gastrointestinal disorders and mast cells: implications for therapy.
@en
type
label
Functional gastrointestinal disorders and mast cells: implications for therapy.
@ast
Functional gastrointestinal disorders and mast cells: implications for therapy.
@en
prefLabel
Functional gastrointestinal disorders and mast cells: implications for therapy.
@ast
Functional gastrointestinal disorders and mast cells: implications for therapy.
@en
P2093
P2860
P1476
Functional gastrointestinal disorders and mast cells: implications for therapy.
@en
P2093
Corinaldesi R
De Giorgio R
Stanghellini V
P2860
P356
10.1111/J.1365-2982.2005.00685.X
P577
2006-01-01T00:00:00Z